scispace - formally typeset
V

Victoria Gregory

Researcher at National Institute for Medical Research

Publications -  22
Citations -  2095

Victoria Gregory is an academic researcher from National Institute for Medical Research. The author has contributed to research in topics: Influenza A virus & H5N1 genetic structure. The author has an hindex of 15, co-authored 22 publications receiving 1924 citations. Previous affiliations of Victoria Gregory include Francis Crick Institute.

Papers
More filters
Journal ArticleDOI

The evolution of human influenza viruses

TL;DR: The evolution of influenza viruses results in recurrent annual epidemics of disease that are caused by progressive antigenic drift of influenza A and B viruses due to the mutability of the RNA genome and infrequent but severe pandemics caused by the emergence of novel influenza A subtypes to which the population has little immunity as mentioned in this paper.
Journal ArticleDOI

Integrating influenza antigenic dynamics with molecular evolution

TL;DR: Previous approaches to antigenic cartography are extended, and simultaneously characterize antigenic and genetic evolution by modeling the diffusion of antigenic phenotype over a shared virus phylogeny, and it is shown that A/H3N2 evolves faster and in a more punctuated fashion than other influenza lineages.
Journal ArticleDOI

Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998.

TL;DR: Although analyses of the surface protein genes of the H5N1 viruses from this outbreak did not provide immediate answers regarding the molecular basis for virulence, the analyses provided clues to potentially important areas of the genes worth further investigation.
Journal ArticleDOI

Neuraminidase Receptor Binding Variants of Human Influenza A(H3N2) Viruses Resulting from Substitution of Aspartic Acid 151 in the Catalytic Site: a Role in Virus Attachment?

TL;DR: The inhibition of NA-dependent agglutination by the inclusion of oseltamivir carboxylate in the assay was effective in restoring the anti-HA specificity of the hemagglutination inhibition (HI) assay for monitoring antigenic changes in HA.